Autopsy report · NCT05006781
The Dose Finding Study of DAOIB Added to tDCS for AD
Cause of deathFunding or business
“The trial was suspended due to the budget issue”
Life of this trial
- Suspended: paused, and may or may not restart.
- 140 participants planned (an estimate, not an actual count).
Vital statistics
- Status
- Suspended
- Phase
- Phase 2
- Sponsor
- Chang Gung Memorial Hospital
- Sponsor type
- University, hospital or other
- Conditions
- Transcranial Direct Current Stimulation; Dementia
- Interventions
- DAOIB
- Participants
- 140 (planned, not actual)
- Sites
- 1
- Countries
- Taiwan
Trials that died the same way
- Department of Defense PTSD Adaptive Platform Trial - Intervention C - Daridorexant
“The trial has been temporarily suspended due to administrative issues” - Development of a Biomarker Directed Strategy to Ameliorate Common Toxicities From Conventional Chemotherapy
“Trial has been suspended due to lack of resource and staff” - Anti-TRBC1 CAR-T Cell Therapy in Patients With TRBC1 Positive T Cell Malignancies
“The trial was suspended due to the inability to enroll qualified participants” - Pancreatic Enzyme Supplementation for Celiac Disease
“The trial was terminated prematurely by the sponsor for administrative reasons.” - Impact of Molecular Testing on Improved Diagnosis, Treatment and Management of CAP
“The trial was stopped earlier than planned after an ad hoc interim analysis”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.